Transactional

Clients ranging from startups and individual entrepreneurs to mature public and private companies, multinational corporations and financial institutions rely on our experienced counsel to turn challenges into business opportunities. 


WilmerHale's Transactional Department includes skilled business counselors and former industry professionals prepared to handle even the most complex transactions and issues, as well as former senior staff members from US government agencies who provide a wealth of regulatory insight. This seasoned team advises clients from a wide array of technology, life sciences and regulated industries, including biotechnology, medical devices, communications, digital media, financial services, energy and cleantech, aviation, education, real estate, retail and the nonprofit sector.

To provide every client with the highest levels of knowledge and experience across a multitude of matters, our Transactional Department attorneys regularly collaborate with the firm's intellectual property, regulatory, securities and litigation authorities. Leading legal publications—including Chambers, The American Lawyer, Law360, The Legal 500 and JUVE—regularly rank our practitioners as the most sophisticated and skilled in the business.

Contacts

Sort By
Singer, Steven D.

Steven D. Singer

Chair, Transactional Department

+1 212 295 6307 (t)

steven.singer@wilmerhale.com

Caporizzo_William_lo

A. William Caporizzo

Vice Chair, Transactional Department

+1 617 526 6411 (t)

william.caporizzo@wilmerhale.com

Anker_Phil.jpg

Philip D. Anker

Partner

+1 212 230 8890 (t)

philip.anker@wilmerhale.com

Bain, Mick

Mick Bain

Partner

+1 617 526 6158 (t)

michael.bain@wilmerhale.com

Barnett, Keith R.

Keith R. Barnett

Partner

+1 617 526 6930 (t)

keith.barnett@wilmerhale.com

Barrett, Steven D.

Steven D. Barrett

Partner

+1 617 526 6238 (t)

steven.barrett@wilmerhale.com

Bonnes, Andrew

Andrew Bonnes

Partner

+1 617 526 6136 (t)

andrew.bonnes@wilmerhale.com

Boot, Jeannette K.

Jeannette K. Boot

Partner

+1 212 295 6507 (t)

jeannette.boot@wilmerhale.com

Borden, Mark G.

Mark G. Borden

Partner

+1 617 526 6675 (t)

mark.borden@wilmerhale.com

Bothwick, Jay E.

Jay E. Bothwick

Partner

+1 617 526 6526 (t)

jay.bothwick@wilmerhale.com

Publications & News

View

November 17, 2017

WilmerHale Reps Achillion Pharmaceuticals in Pricing of Secondary Offering of Common Stock

Achillion Pharmaceuticals, Inc. announced the pricing of an underwritten public offering of 18,367,346 shares of its common stock by existing stockholder Johnson & Johnson Innovation-JJDC, Inc., which shares constitute all of JJDC's equity position in Achillion, at a public offering price of $2.75 per share.

November 14, 2017

WilmerHale Reps Apellis Pharmaceuticals in Initial Public Offering

Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, announced the closing of its initial public offering.

November 9, 2017

WilmerHale Counsels Kindred Systems’ $28M Series B Financing

Kindred Systems Inc., a Vancouver-based developer of human-like intelligence in machines, has secured approximately $28 million in a Series B financing, bringing its total funding to $44 million.

November 7, 2017

LMG Life Sciences 2017 Honors WilmerHale With Top Rankings

LMG Life Sciences has recognized WilmerHale among the nation's leading life sciences law firms in its 2017 rankings, citing the firm's Life Sciences Practice as “renowned for its range and multidisciplinary teams that counsel clients in technology, pharmaceutical and medical device companies as well as investment banks and venture capitalists.”

November 6, 2017

WilmerHale Represents 1366 Technologies in $9M Series D Funding

Developer of manufacturing solutions for silicon cell manufacturers, 1366 Technologies, has raised $9 million in Series D funding from strategic partners and return investors.

November 1, 2017

WilmerHale Honored Throughout 2018 U.S. News - Best Lawyers® Best Law Firms List, Named Intellectual Property Litigation Firm of the Year

WilmerHale has been recognized among the 2018 U.S. News and World Report and Best Lawyers® list of Best Law Firms, an honor it has earned since the inception of these rankings in 2010.

October 31, 2017

Competition Impact Review to Be Required for All New Chinese Regulations

China's three Anti-Monopoly Law enforcement agencies—the National Development and Reform Commission, the Ministry of Commerce, and the State Administration for Industry and Commerce—together with the Ministry of Finance and the State Council Legislative Affairs Office, on October 26 jointly published the Rules on Implementation of the Fair Competition Review System (for temporary effect) (Fa Gai Jia Jian [2017] No. 1849).

October 30, 2017

WilmerHale Represents Consumer Physics in $4.95M Series C Funding

Consumer Physics—developer of SCiO, the world's first pocket-sized connected micro-spectrometer—completed its Series C financing round raising a total of $4.95 million.

October 26, 2017

WilmerHale Reps Franklin Street Properties in $1B Recast of Unsecured Credit Facility

Franklin Street Properties Corporation announced that it has successfully entered into the following transactions: recast of existing unsecured credit facility into $1 billion facility and private placement of $200 million senior unsecured notes.

October 26, 2017

WilmerHale Reps MacroGenics in Global Collaboration and Licensing Agreement With Incyte

MacroGenics, Inc. and Incyte Corporation announced that they have entered into an exclusive global collaboration and license agreement for MacroGenics' MGA012, an investigational monoclonal antibody that inhibits programmed cell death protein 1 (PD-1).